Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-18-000021
Filing Date
2018-02-09
Accepted
2018-02-09 21:16:27
Documents
1
Period of Report
2018-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151822897304817.html 4  
1 FORM 4 wf-form4_151822897304817.xml 4 5726
  Complete submission text file 0001479290-18-000021.txt   7058
Mailing Address 15279 ALTON PARKWAY SUITE #100 IRVINE CA 92618
Business Address
SILVERNAIL LAUREN P (Reporting) CIK: 0001225755 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 18593654

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations